The tumor volume, weight and tumor inhibition rate in BRCA1 + NP and BRCA2 + NP treatment groups were significantly lowered, indicating role of wild type BRCA1 and BRCA2 in the tumor microenvironment. The gene discussed is BRCA1; the disease is neoplasm.